Mankind Pharma Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
25 Apr 2023Close Date
27 Apr 2023Size (in Crs.)
4326.36
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
-54Lot Size
13
Type
Book building
Face Value
1
Market Lot
1
Objective of the Issue
(i) carry out the Offer for Sale of 40,058,844 Equity Shares by the Selling Shareholders aggregating to ? [?] million.(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Description
We are India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022 (Source: IQVIA Dataset, IQVIA TSA MAT March 2022 Dataset for India (For FY20-22)). We are engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. We are focused on the domestic market, as a result of which our revenue fr... Show More
Address
208 , Okhla Industrial Estate , Phase - 111
New Delhi
110020
Promoter Holding
Promoters:
Prem Sheetal Family Trust, Rajeev Juneja, Rajeev Juneja Family Trust, Ramesh Juneja , Ramesh Juneja Family Trust, Sheetal Arora
Total Share Capital
316464857
Offered to Public
40058844
% Promoter's Holding (Pre-Issue)
79
% Promoter's Holding (Post-Issue)
76.5
Shares on offer
Total Share Offer
316464857
Of above offred to public
40058844
Post Issue shares
NA
Post Issue Promoters
76.5
Lead Managers to the Issue:
Axis Capital Ltd., IIFL Securities Ltd., Jefferies India Pvt Ltd., JP Morgan India Pvt Ltd, Kotak Mahindra Capital Co Ltd
Registrar Details
Registrar Name:
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Address
Karvy Selenium Tower B, Plot 31-32 , Gachibowli,Financial District , Nanakramguda , Hyderabad
500032